At PharmaForceIQ, we know that behind every data point in rare disease is a patient who may have spent years desperately seeking a correct diagnosis. When those answers finally come, the window to begin life-changing treatment is often heartbreakingly narrow, making it critical that healthcare providers have immediate access to the right medical information.
In this article, our Chief Executive and Strategy Officer, Hemal Somaiya, explains why we must move away from delayed, “spray-and-pray” campaigns that ultimately fail the clinicians and families relying on them. Instead, we explore how embracing a proactive optichannel approach allows us to listen to real-world signals like a recent lab test to deliver truly personalized, customer-centric support to doctors exactly when they are making critical care decisions. By capturing the earliest signals of a patient journey, such as lab data, these campaigns can initiate HCP engagement within just 24 to 48 hours of a test result. Furthermore, predictive models can be used to anticipate new diagnoses or treatment switches, while behavioral signals (like search queries and publication downloads) help identify high-intent moments.
Ultimately, by replacing guesswork with meaningful, timely connections, we can build trust, empower lean healthcare teams, and ensure that vital therapies reach the patients who need them most
Please note: This is gated content. You will need to create an account to access it.